HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benralizumab for Chronic Spontaneous Urticaria.

AuthorsJonathan A Bernstein, Umesh Singh, Marepalli B Rao, Karen Berendts, Xiang Zhang, Diya Mutasim
JournalThe New England journal of medicine (N Engl J Med) Vol. 383 Issue 14 Pg. 1389-1391 (10 01 2020) ISSN: 1533-4406 [Electronic] United States
PMID32997916 (Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Interleukin-5 Receptor alpha Subunit
  • benralizumab
Topics
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Chronic Urticaria (drug therapy)
  • Female
  • Humans
  • Injections, Subcutaneous
  • Interleukin-5 Receptor alpha Subunit (antagonists & inhibitors)
  • Male
  • Middle Aged
  • Single-Blind Method

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: